Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Gross Profit of $533.8 thousand for fiscal year 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $533.8K | -30.4% |
| 2023 | $766.4K | +1837.4% |
| 2022 | $39.6K | +122.4% |
| 2021 | -$176.2K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -30.4% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2024 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s gross profit has grown by 402.9% (from -$176.2 thousand to $533.8 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: